Loperamide Hydrochloride Patent Expiration

Loperamide Hydrochloride is used for treating symptoms of anxiety and panic disorders. It was first introduced by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div in its drug Imodium on Approved Prior to Jan 1, 1982. Other drugs containing Loperamide Hydrochloride are Imodium A-D Ez Chews, Loperamide Hydrochloride, Imodium A-D. 28 different companies have introduced drugs containing Loperamide Hydrochloride.


Loperamide Hydrochloride Patents

Given below is the list of patents protecting Loperamide Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Imodium A-d Ez Chews US6814978 Process for preparing a soft tablet Aug 26, 2021

(Expired)

J And J Consumer Inc
Imodium A-d Ez Chews US5489436 Taste mask coatings for preparation of chewable pharmaceutical tablets Feb 06, 2013

(Expired)

J And J Consumer Inc



Loperamide Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Loperamide Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Loperamide Hydrochloride. The first generic version for Loperamide Hydrochloride was by Teva Pharmaceuticals Usa Inc and was approved on Aug 30, 1991. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Sep 5, 2023.

Given below is the list of companies who have filed for Loperamide Hydrochloride generic, along with the locations of their manufacturing plants worldwide.